Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Sophie Robert, PharmD - An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
1
x
$
30.00
A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder
1
x
$
30.00
Branimir Margetic: A Case of Stuttering During Treatment with Levomepromazine
1
x
$
30.00
Psychopharmacology Bulletin VOL 47 No. 2, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
1
x
$
30.00
View Cart
Checkout
Home
Thomas J. Raedler, MD: Lithium-Induced Nephropathies
Thomas J. Raedler, MD: Lithium-Induced Nephropathies
$
30.00
Thomas J. Raedler, MD: Lithium-Induced Nephropathies quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 2 Articles
Tags:
lithium
,
md
,
md-klaus-wiedemann
,
nephrogenic-diabetes-insipidus
,
nephropathy
,
renal-insufficiency
,
thomas-j-raedler
Description
Description
Thomas J. Raedler, MD
COMPLICATED CASE HISTORIES
Lithium-Induced Nephropathies
Thomas J. Raedler, MD and Klaus Wiedemann, MD
Related products
Larry Alphs, MD, PhD: Asenapine in the Treatment of Negative Symptoms of Schizophrenia: Clinical Trial Design and Rationale
$
30.00
Add to cart
Details
Eileen P. Ahearn, MD, PhD: Fear, Anxiety, and the Neuroimaging of PTSD
$
30.00
Add to cart
Details
Ethical Issues In Schizophrenia: Considerations for Treatment and Research
$
0.00
Add to cart
Details
David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
